Z-0318-2026 Class I Ongoing
FDA device recall Z-0318-2026 was initiated by Dexcom, Inc. on Aug 28, 2025 and is designated Class I. Reason for recall: A software defect in version v1.15.0 of the G6 Android app can cause the app to terminate unexpectedly, which may result in the user not receiving estimated glucose values, alarms, alerts or… The recall status is ongoing. Affected quantity: 333.
Recall details
- Product Type
- Devices
- Report Date
- Nov 5, 2025
- Initiation Date
- Aug 28, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 333
Product description
Reason for recall
Distribution pattern
This product was distributed throughout the US. G6 Android US v1.15.0 SW11678 G6 and G6 Pro Android app release has been halted <1% rollout after this issue was identified. Please see the attached consignee data for additional details.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0318-2026
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Dexcom, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.